Clinical trial
DuraTouch® - Post-Market Clinical Follow-up (PMCF) Study in a Real-world Setting
NCT07052292 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DuraTouch® - Post-Market Clinical Follow-up (PMCF) Study in a Real-world Setting
- Lead sponsor
- Novo Nordisk A/S
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 1, 2025
- Completion date
- January 9, 2026
- Enrollment
- 128 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.